ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.580
+0.150 (3.39%)
Feb 13, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.98 billion as of February 13, 2026. Its market cap has decreased by -3.54% in one year.
Market Cap
1.98B
Enterprise Value
1.37B
Revenue
134.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.58
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.98B, a decrease of -72.87%. That is a compound annual growth rate of -41.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.91B | -24.01% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.42B |
| SinoMab BioScience | 2.41B |
| Antengene Corporation | 2.37B |
| Mabpharm | 2.10B |
| Frontage Holdings | 2.07B |
| Zhaoke Ophthalmology | 1.90B |
| Cutia Therapeutics | 1.84B |
| CANbridge Pharmaceuticals | 1.61B |